Figure 3From: An evaluation of the brain distribution of [11C]GSK1034702, a muscarinic-1 (M1) positive allosteric modulator in the living human brain using positron emission tomographyClinical Study plasma concentration of GSK1034702 over time (in h). Subjects were scanned between 3 and 5 h after a single oral dose of GSK1034702. Figure 3 shows that PK levels of GSK1034702 had reached a peak in all subjects prior to the acquisition of the PET data.Back to article page